TrianglePUBLICATIONS · 3884128
Treatment of recurrent or advanced uterine sarcoma. A randomized trial of doxorubicin versus doxorubicin and cyclophosphamide (a phase III trial of the Gynecologic Oncology Group).
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Cancer
- Publication date
- 1985 Apr 15
- First author
- Muss HB
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Muss HB
- type
- Author
- name
- Bundy B
- type
- Author
- name
- DiSaia PJ
- type
- Author
- name
- Homesley HD
- type
- Author
- name
- Fowler WC Jr
- type
- Author
- name
- Creasman W
- type
- Author
- name
- Yordan E
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Muss HB
- type
- Author
- name
- Bundy B
- type
- Author
- name
- DiSaia PJ
- type
- Author
- name
- Homesley HD
- type
- Author
- name
- Fowler WC Jr
- type
- Author
- name
- Creasman W
- type
- Author
- name
- Yordan E
- type
- Author
- bibliography ids
- nci-bib-171dc9a6fa92c1435e5cb26f
- book metadata
- content sha256
- cf3f87d9416e6f7efbdc1f2ca59173c23c85306190906c8fe31c90d616cbac0b
- document type
- citation
- dois
- 10.1002/1097-0142(19850415)55:8<1648::aid-cncr2820550806>3.0.co;2-7
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:3884128
- immutable id
- pubmed:3884128@cf3f87d9416e6f7efbdc1f2ca59173c23c85306190906c8fe31c90d616cbac0b
- journal
- abbreviation
- Cancer
- issn electronic
- Source null
- issn print
- 0008-543X
- issue
- 8
- name
- Cancer
- nlm unique id
- 0374236
- pages
- 1648-53
- volume
- 55
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 3884128
- provenance
- batch id
- 45403cd8e23f91d9edb9
- provider
- NCBI PubMed ESummary
- record sha256
- c45cb0feafaed9cff8d292ac530a598886d2057f0b11b5542087ad5adf1de6cc
- response sha256
- 67aea2123a1ac51343b6dac62187e007efabbd6172b000ecba1c9d0afe20513a
- retrieved at
- 2026-09-09T23:45:14.686855+00:00
- publication date
- display
- 1985 Apr 15
- precision
- day
- year
- 1985
- publication types
- Clinical Trial
- Journal Article
- Randomized Controlled Trial
- Research Support, U.S. Gov't, P.H.S.
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- source url
- https://pubmed.ncbi.nlm.nih.gov/3884128/
- title
- Treatment of recurrent or advanced uterine sarcoma. A randomized trial of doxorubicin versus doxorubicin and cyclophosphamide (a phase III trial of the Gynecologic Oncology Group).
Preserved source evidence · Not medical advice